Results 161 to 170 of about 3,928,365 (313)
volume 19, no. 3 (July 2016) [PDF]
Office of Alumni Engagement, Bryant University
core +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source
Component analysis of a self-monitoring intervention for increasing task engagement for individuals with developmental disabilities. [PDF]
Leif E, Roscoe E, Rae L, Sheets S.
europepmc +1 more source
volume 21, no. 4 (October 2017) [PDF]
Office of Alumni Engagement, Bryant University
core +1 more source
ABSTRACT Introduction Progressive Supranuclear Palsy (PSP) is a neurodegenerative ‘tauopathy’ with predominating pathology in the basal ganglia and midbrain. Caudal tau spread frequently implicates the cerebellum; however, the pattern of atrophy remains equivocal.
Chloe Spiegel +8 more
wiley +1 more source
Making room for patients in economic evaluation: a commentary on current capacity and future directions. [PDF]
Thompson ER +12 more
europepmc +1 more source
volume 20, no. 2 (April 2017) [PDF]
Office of Alumni Engagement, Bryant University
core +1 more source
CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang +6 more
wiley +1 more source
Portrayals of Depression on TikTok: Content Analysis of Diagnostic Accuracy, Creator Type, and Stylistic Features. [PDF]
Rainer E, van der Wal A, Beyens I.
europepmc +1 more source

